share_log

AbbVie | 4: Statement of changes in beneficial ownership of securities-Officer Donoghoe Nicholas

AbbVie | 4: Statement of changes in beneficial ownership of securities

艾伯維公司 | 4:持股變動聲明
SEC announcement ·  03/23 05:03
牛牛AI助理已提取核心訊息
Nicholas Donoghoe, EVP, CHIEF BUS/STRAT OFFICER of AbbVie Inc. (ABBV), completed a sale of 21,082 shares of common stock on March 20, 2024. The shares were sold at a price of $176.3 each, resulting in a total transaction value of $3,716,756.60. Following the transaction, Donoghoe directly holds 55,903 shares of the company. The sale was conducted as an open market or private sale, and the transaction has been reported as completed.
Nicholas Donoghoe, EVP, CHIEF BUS/STRAT OFFICER of AbbVie Inc. (ABBV), completed a sale of 21,082 shares of common stock on March 20, 2024. The shares were sold at a price of $176.3 each, resulting in a total transaction value of $3,716,756.60. Following the transaction, Donoghoe directly holds 55,903 shares of the company. The sale was conducted as an open market or private sale, and the transaction has been reported as completed.
艾伯維公司(ABBV)執行副總裁兼首席公共汽車/戰略官尼古拉斯·多諾霍於2024年3月20日完成了21,082股普通股的出售。這些股票以每股176.3美元的價格出售,總交易價值爲3,716,756.60美元。交易完成後,Donoghoe直接持有該公司的55,903股股份。此次出售是以公開市場或私人銷售的形式進行的,據報告交易已完成。
艾伯維公司(ABBV)執行副總裁兼首席公共汽車/戰略官尼古拉斯·多諾霍於2024年3月20日完成了21,082股普通股的出售。這些股票以每股176.3美元的價格出售,總交易價值爲3,716,756.60美元。交易完成後,Donoghoe直接持有該公司的55,903股股份。此次出售是以公開市場或私人銷售的形式進行的,據報告交易已完成。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。